Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Septic shock.

Djillali Annane1, Eric Bellissant, Jean-Marc Cavaillon

  • 1Service de Réanimation, Hôpital Raymond Poincaré, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Paris Ile de France Ouest, Université de Versailles Saint Quentin en Yvelines, Garches, France. djillali.annane@rpc.aphp.fr

Lancet (London, England)
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HydrOcortisone and fludRocortisoNe for critical ILLness-related corticosteroid insufficiency (HORNbILL): study protocol for a multicentre randomised placebo-controlled trial.

BMJ open·2026
Same author

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP).

Critical care medicine·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Rethinking fairness in unsupervised healthcare AI: A methodological scoping review.

Journal of biomedical informatics·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
See all related articles

Septic shock, a severe sepsis complication, involves complex immune responses. Early intervention controlling infection and hemodynamics is crucial, with ongoing research into optimal fluids, vasopressors, and novel therapies.

Area of Science:

  • Immunology
  • Critical Care Medicine
  • Pathophysiology

Background:

  • Septic shock is a life-threatening condition and a severe complication of sepsis.
  • Recent advancements have improved understanding of its complex pathophysiology and treatment strategies.
  • The disease involves intricate sequential intracellular events triggered by pathogens in various body systems.

Purpose of the Study:

  • To review the current understanding of septic shock pathophysiology.
  • To discuss the critical time-window for effective interventions.
  • To highlight areas for further research in fluid and vasopressor therapy, and novel treatment strategies.

Main Methods:

  • Review of current literature on septic shock.
  • Analysis of inflammatory and anti-inflammatory mediator roles.

Related Experiment Videos

  • Discussion of established and emerging therapeutic approaches.

    • Main Results:

    • Pathogens trigger sequential intracellular events involving immune cells, epithelium, endothelium, and the neuroendocrine system.
    • Both proinflammatory and anti-inflammatory mediators play critical roles, leading to tissue damage and immune status changes.
    • Effective treatment requires prompt source control and hemodynamic stabilization.

    Conclusions:

    • Early and decisive intervention is paramount in managing septic shock.
    • Optimal fluid and vasopressor choices require further research.
    • Investigational therapies targeting mediators, endothelium, and the neuroendocrine system show promise.